Refractory ovarian carcinoma Clinical Trials

Delta Trials tracks 13 clinical trials for Refractory ovarian carcinoma in its publicly accessible dataset. Among the listed trials, 4 open for participant enrollment and 4 trials have reached completion. This research is carried out at 26 clinical sites around the world. An additional 5 trials have active registrations outside the recruiting and completed categories. Since 2020, 3 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.